Rabson–Mendenhall syndrome

Rabson–Mendenhall syndrome is a rare genetic disorder characterized by severe insulin resistance. It is part of a group of conditions known as insulin receptor disorders, which also includes Donohue syndrome and type A insulin resistance syndrome. The syndrome is named after Dr. S. M. Rabson and Dr. L. S. Mendenhall, who first described the condition.
Clinical Features[edit]
Individuals with Rabson–Mendenhall syndrome typically present with a range of symptoms that may include:
- Severe insulin resistance
- Hyperglycemia
- Acanthosis nigricans
- Dysplastic teeth
- Hirsutism
- Pineal hyperplasia
- Growth retardation
Genetics[edit]
Rabson–Mendenhall syndrome is caused by mutations in the INSR gene, which encodes the insulin receptor. This gene is located on chromosome 19. The condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
Diagnosis[edit]
Diagnosis of Rabson–Mendenhall syndrome is based on clinical features and confirmed by genetic testing. Laboratory tests typically show elevated levels of insulin and glucose in the blood, indicating severe insulin resistance.
Treatment[edit]
There is no cure for Rabson–Mendenhall syndrome, and treatment is primarily supportive. Management strategies may include:
- High doses of insulin
- Dietary modifications
- Metformin and other insulin-sensitizing agents
- Monitoring and treatment of complications such as diabetes mellitus and hyperglycemia
Prognosis[edit]
The prognosis for individuals with Rabson–Mendenhall syndrome varies. The condition is often severe and can lead to significant health complications. Early diagnosis and management are crucial for improving outcomes.
See Also[edit]
- Insulin receptor disorders
- Donohue syndrome
- Type A insulin resistance syndrome
- Hyperglycemia
- Acanthosis nigricans
References[edit]
External Links[edit]
-
| Medical Condition | |
|---|---|
| [[File:|250px|alt=|]] | |
| Synonyms | N/A |
| Pronounce | N/A |
| Field | N/A |
| Symptoms | N/A |
| Complications | N/A |
| Onset | N/A |
| Duration | N/A |
| Types | N/A |
| Causes | N/A |
| Risks | N/A |
| Diagnosis | N/A |
| Differential diagnosis | N/A |
| Prevention | N/A |
| Treatment | N/A |
| Medication | N/A |
| Prognosis | N/A |
| Frequency | N/A |
| Deaths | N/A |
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
